Published online before print January 20, 2004, doi: 10.1161/01.CIR.0000114527.10764.CC
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:506-512.)
© 2004 American Heart Association, Inc.
Basic Science Reports |
Biological Pacemaker Implanted in Canine Left Bundle Branch Provides Ventricular Escape Rhythms That Have Physiologically Acceptable Rates
From the Center for Molecular Therapeutics, Departments of Pharmacology and Pediatrics, College of Physicians and Surgeons of Columbia University, New York, NY.
Correspondence to Michael R. Rosen, MD, Gustavus A. Pfeiffer Professor of Pharmacology, Professor of Pediatrics, College of Physicians & Surgeons of Columbia University, Department of Pharmacology, 630 W 168th St, PH7West-321, New York, NY 10032. E-mail mrr1{at}columbia.edu
Received October 8, 2003; revision received December 4, 2003; accepted December 11, 2003.
Background— We hypothesized that administration of the HCN2 gene to the left bundle-branch (LBB) system of intact dogs would provide pacemaker function in the physiological range of heart rates.
Methods and Results— An adenoviral construct incorporating HCN2 and green fluorescent protein (GFP) as a marker was injected via catheter under fluoroscopic control into the posterior division of the LBB. Controls were injected with an adenoviral construct of GFP alone or saline. Animals were monitored electrocardiographically for up to 7 days after surgery, at which time they were anesthetized and subjected to vagal stimulation to permit emergence of escape pacemakers. Hearts were then removed and injection sites visually identified and removed for microelectrode study of action potentials, patch clamp studies of pacemaker current, and/or immunohistochemical studies of HCN2. For 48 hours postoperatively, 7 of 7 animals subjected to 24-hour ECG monitoring showed multiple ventricular premature depolarizations and/or ventricular tachycardia attributable to injection-induced injury. Thereafter, sinus rhythm prevailed. During vagal stimulation, HCN2-injected dogs showed rhythms originating from the left ventricle, the rate of which was significantly more rapid than in the controls. Excised posterior divisions of the LBB from HCN2-injected animals manifested automatic rates significantly greater than the controls. Isolated tissues showed immunohistochemical and biophysical evidence of overexpressed HCN2.
Conclusions— A gene-therapy approach for induction of biological pacemaker activity within the LBB system provides ventricular escape rhythms that have physiologically acceptable rates. Long-term stability and feasibility of the approach remain to be tested.
Key Words: arrhythmia • electrophysiology • gene therapy • pacemakers
This article has been cited by other articles:
 |
|
 |
|
  V. Valiunas, G. Kanaporis, L. Valiuniene, C. Gordon, H. Z. Wang, L. Li, R. B. Robinson, M. R. Rosen, I. S. Cohen, and P. R. Brink Coupling an HCN2-expressing cell to a myocyte creates a two-cell pacing unit J. Physiol., November 1, 2009; 587(21): 5211 - 5226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Macia and P. A. Boyden Stem Cell Therapy Is Proarrhythmic Circulation, April 7, 2009; 119(13): 1814 - 1823. [Full Text] [PDF]
|
|
|
|
|
|
E. Accili Putting the pacemaker channel through its paces to build a better biological pacemaker J. Physiol., April 1, 2009; 587(7): 1381 - 1382. [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, A. Bucchi, R. V. Oren, Y. Kryukova, W. Dun, C. E. Clancy, and R. B. Robinson In vitro characterization of HCN channel kinetics and frequency dependence in myocytes predicts biological pacemaker functionality J. Physiol., April 1, 2009; 587(7): 1513 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Rosen, P. R. Brink, I. S. Cohen, and R. B. Robinson Cardiac Pacing: From Biological to Electronic ... to Biological? Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 54 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Plotnikov, I. Shlapakova, M. J. Szabolcs, P. Danilo Jr, B. H. Lorell, I. A. Potapova, Z. Lu, A. B. Rosen, R. T. Mathias, P. R. Brink, et al. Xenografted Adult Human Mesenchymal Stem Cells Provide a Platform for Sustained Biological Pacemaker Function in Canine Heart Circulation, August 14, 2007; 116(7): 706 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kashiwakura, H. C. Cho, A. S. Barth, E. Azene, and E. Marban Gene Transfer of a Synthetic Pacemaker Channel Into the Heart: A Novel Strategy for Biological Pacing Circulation, October 17, 2006; 114(16): 1682 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Cowan and F. X. McGowan Jr A Paradigm Shift in Cardiac Pacing Therapy? Circulation, September 5, 2006; 114(10): 986 - 988. [Full Text] [PDF]
|
|
|
|
|
|
A. Bucchi, A. N. Plotnikov, I. Shlapakova, P. Danilo Jr, Y. Kryukova, J. Qu, Z. Lu, H. Liu, Z. Pan, I. Potapova, et al. Wild-Type and Mutant HCN Channels in a Tandem Biological-Electronic Cardiac Pacemaker Circulation, September 5, 2006; 114(10): 992 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-F. Tse, T. Xue, C.-P. Lau, C.-W. Siu, K. Wang, Q.-Y. Zhang, G. F. Tomaselli, F. G. Akar, and R. A. Li Bioartificial Sinus Node Constructed via In Vivo Gene Transfer of an Engineered Pacemaker HCN Channel Reduces the Dependence on Electronic Pacemaker in a Sick-Sinus Syndrome Model Circulation, September 5, 2006; 114(10): 1000 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Choi, C. Stamm, P. E. Hammer, K. F. Kwaku, J. J. Marler, I. Friehs, M. Jones, C. M. Rader, N. Roy, M.-T. Eddy, et al. Cardiac Conduction through Engineered Tissue Am. J. Pathol., July 1, 2006; 169(1): 72 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Robinson, M. R. Rosen, P. R. Brink, I. S. Cohen, T. Xue, and R. A. Li Letter Regarding the Article by Xue et al, "Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes" * Response Circulation, August 9, 2005; 112(6): e82 - e83. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zicha, M. Fernandez-Velasco, G. Lonardo, N. L'Heureux, and S. Nattel Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model Cardiovasc Res, June 1, 2005; 66(3): 472 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kizana, S. L. Ginn, D. G. Allen, D. L. Ross, and I. E. Alexander Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling Circulation, February 1, 2005; 111(4): 394 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Qu, Y. Kryukova, I. A. Potapova, S. V. Doronin, M. Larsen, G. Krishnamurthy, I. S. Cohen, and R. B. Robinson MiRP1 Modulates HCN2 Channel Expression and Gating in Cardiac Myocytes J. Biol. Chem., October 15, 2004; 279(42): 43497 - 43502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rosen, P. R. Brink, I. S. Cohen, and R. B. Robinson Genes, stem cells and biological pacemakers Cardiovasc Res, October 1, 2004; 64(1): 12 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Potapova, A. Plotnikov, Z. Lu, P. Danilo Jr, V. Valiunas, J. Qu, S. Doronin, J. Zuckerman, I. N. Shlapakova, J. Gao, et al. Human Mesenchymal Stem Cells as a Gene Delivery System to Create Cardiac Pacemakers Circ. Res., April 16, 2004; 94(7): 952 - 959. [Abstract] [Full Text] [PDF]
|
|